Light- and heavy-chain deposition disease (LHCDD): Difficulty in diagnosis and treatment

Internal Medicine

Volumn 44, Issue 9, 2005, Pages 915-916

  Suzuki, Kenshi ^a  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Light and heavy chain deposition disease (LHCDD); PBSCT; Renal failure

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; M PROTEIN; MELPHALAN; PLATELET DERIVED GROWTH FACTOR B; PREDNISONE; SCLEROPROTEIN; VINCRISTINE;

ADULT; AGAR GEL ELECTROPHORESIS; ALLOGENEIC STEM CELL TRANSPLANTATION; AMYLOIDOSIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; CASE REPORT; CLINICAL FEATURE; EDITORIAL; GLOMERULOSCLEROSIS; HEAVY CHAIN DISEASE; HEMATURIA; HUMAN; HYPERTENSION; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOLOGY; KIDNEY BIOPSY; KIDNEY FAILURE; LIGHT AND HEAVY CHAIN DEPOSITION DISEASE; LIGHT CHAIN; MALE; MOLECULAR BIOLOGY; MULTIPLE MYELOMA; PLASMA CELL DYSCRASIA; PROGNOSIS; PROTEINURIA; SKIN BIOPSY; SYMPTOMATOLOGY;

ANTINEOPLASTIC AGENTS; HEAVY CHAIN DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; PARAPROTEINEMIAS; PROGNOSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 27844592697     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.915     Document Type: Editorial

References (5)

1. Buxbaum J. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol Oncol Clin North Am 6: 323-346, 1992.
2. Gallo GR, Lazowski P, Kumar A, et al. Renal and cardiac manifestations of B-cell dyscrasias with nonamyloidotic monoclonal light chain and light and heavy chain deposition diseases. Adv Nephrol Necker Hosp 28: 355-382, 1998.
3. Sakakima M, Fujigaki Y, Tsuji T, et al. High dose chemotherapy and stem cell support in a patient of light- and heavy-chain deposition disease with abnormal marrow cell surface antigens and no monoclonal protein. Intern Med 44: 970-974, 2005.
4. Fermand JP, Ravaud P, Chevret S, et al. High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: Up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial. Blood 92: 3131-3136, 1998.
5. Skinner M, Sanchorawala V, Seldin DC, et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study. Ann Intern Med 140: 85-93, 2004.